Trial of GMO cassava now awaits commercialization
The GM cassava varieties were developed by the Kenya Agricultural and Livestock Research Organisation (KALRO) to resist Cassava Brown Streak Disease (CBSD), which causes browning and malformation of edible roots, and to improve drought tolerance. Kenya breaking news | Kenya news ..
✨ Key Highlights
Kenya has completed national performance trials (NPTs) for genetically modified (GM) cassava, moving closer to commercial release. These disease-resistant varieties aim to bolster food security by combating Cassava Brown Streak Disease (CBSD) and improving drought tolerance.
- The GM cassava varieties were developed by the Kenya Agricultural and Livestock Research Organisation (KALRO).
- Acting Director of Technical Services Josphat Muchiri of the National Biosafety Authority (NBA) announced the completion of trials.
- Kenya has previously commercialized Bt cotton, grown on about 10,000 acres, with Bt maize approved for 2025 rollout before court orders halted it.
Continue Reading
Read the complete article from Capital Business
Part of the Day's Coverage
Kenya Pursues Initiatives in Trade, Aviation, and Agriculture - January 2026
Kenya has secured a preliminary trade deal with China, granting near-zero tariff access for 98.2 percent of Kenyan exports to the Chinese market. This "early harvest" agreement aims to boost agricultural exports and address Kenya's trade deficit. In another partnership, Kenya is working with a leading Chinese university to train aviation professionals, aiming to become a regional hub for advanced aviation skills. This initiative addresses Africa's growing shortage of aviation professionals. Domestically, Kenya has completed national performance trials for genetically modified (GM) cassava, moving closer to commercial release. These disease-resistant varieties aim to bolster food security by combating Cassava Brown Streak Disease and improving drought tolerance.
